elsunersen
elsunersen: sourced relationships with 1 company · 1 clinical trial tracked.
elsunersen evidence translation
What we can confirm
1 tracked trial
What it means
What to watch
Prepared research question
How could elsunersen → PRAX affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Praxis Precision Medicines, Inc. (PRAX) Epileptic Encephalopathy | Phase 3 |
Clinical Trial Registry Records (1)
A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
Primary endpoint: To assess the efficacy of elsunersen on seizure frequency in participants with early-onset SCN2A DEE
Frequently asked questions
Which companies have sourced relationships with elsunersen?
elsunersen has dated SEC/FDA relationship records for Praxis Precision Medicines, Inc..
How many clinical trials involve elsunersen?
BioSniper tracks 1 clinical trial involving elsunersen.